Under the new plan, Medicare beneficiaries in the continental U.S. can choose from two SilverScript plans that offer a $0 deductible in 47 states on formulary drugs in all five drug tiers. Drug tiers indicate the level of cost-sharing for a covered drug — for example, beneficiaries typically pay lower co-pays for drugs in lower tiers. In addition, beneficiaries will have $0 co-pays for 90-day supplies of Tier 1 drugs when using CVS Caremark Mail Service Pharmacy and lower premiums than 2017 in 48 states.
“For 2018 we have worked to reduce premiums for the majority of SilverScript plans across the country and to provide beneficiaries in our plans with continued access to a $0 deductible for drugs on all tiers,” said SilverScript Insurance Co. president Todd Meek.
SilverScript Choice is a basic plan that offers comprehensive coverage with competitive premiums, $0 deductible on all covered drugs in 47 states, and $0 co-pays for 90-day supplies of Tier 1 drugs nationwide when filled through the CVS Caremark Mail Service Pharmacy.
New to the SilverScript Choice Plan this year, beneficiaries managing diabetes can take advantage of significant savings on long-acting insulin drugs. In fact, for 2018, three injectable insulin medications will be covered in Tier 2 — down-tiered from Tier 3 in 2017. This may represent a potential savings of 60% to 75% (compared to 2017 co-pays for 30-day supplies) for each prescription filled for these drugs during Medicare’s initial coverage stage.
SilverScript Plus is an enhanced plan that provides additional coverage in the coverage gap (or donut hole). The Plus plan is designed for people who take several medications on a regular basis and are likely to reach the coverage gap during the 2018 plan year. SilverScript Plus offers lower monthly premiums than in 2017, $0 deductible on all covered drugs, and $0 co-pays for 90-day supplies of both Tier 1 and Tier 2 drugs nationwide through the CVS Caremark Mail Service Pharmacy.
SilverScript Plus beneficiaries can also save on their drug costs by using a preferred pharmacy in a network that includes more than 37,000 retail pharmacies, including leading national chains, plus thousands of regional and local independent pharmacies across the country.
SilverScript maintained its four-star performance rating from Centers for Medicare and Medicaid Management (CMS) for 2018, surpassing industry standards in delivering value, clinical outcomes and customer service. CMS annually evaluates and rates plan performance of Medicare Part D prescription drug plans based on quality, value and service measures. Plans are scored on a scale of one to five, with five stars being the highest achievable rating.
Enrollment during the Medicare Annual Enrollment Period for the 2018 plan year began October 15, 2017, and will end December 7, 2017.